Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business Highlights
BOSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. NASDAQ:CUE, a clinical stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, today reported third quarter 2026 financial results as well as recent business highlights.“We are seeing exciting mom…